A whole cell pathway screen reveals seven novel chemosensitizers to combat chloroquine resistant malaria

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Ch'Ng, Jun Hong ^a   Mok, Sachel ^b   Bozdech, Zbynek ^b   Lear, Martin James ^c   Boudhar, Aicha ^a   Russell, Bruce ^a   Nosten, Francois ^d,e   Tan, Kevin Shyong Wei ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c TOHOKU UNIVERSITY   (Japan)

^d SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^e Center for Clinical Vaccinology and Tropical Medicine   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE;

ANIMAL; ARTICLE; DRUG EFFECT; DRUG RESISTANCE; DRUG SCREENING; MALARIA; METHODOLOGY; PARASITE; PARASITOLOGY; PLASMODIUM FALCIPARUM; DRUG EFFECTS; PROCEDURES;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE; MALARIA; PARASITES; PLASMODIUM FALCIPARUM;

EID: 84877735534     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01734     Document Type: Article

References (33)

1. Mita, T., Tanabe, K. & Kita, K. Spread and evolution of Plasmodium falciparum drug resistance. Parasitol Int 58, 201-209 (2009).
2. Dondorp, A. M. et al. Artemisinin Resistance in Plasmodium falciparum Malaria. New England Journal of Medicine 361, 455-467 (2009).
3. Rottmann, M. et al. Spiroindolones, a potent compound class for the treatment of malaria. Science 329, 1175-1180 (2010).
4. Vaidya, A. B. & Mather, M. W. Atovaquone resistance in malaria parasites. Drug Resist Updat 3, 283-287 (2000).
5. Egan, T. J. & Kaschula, C. H. Strategies to reverse drug resistance in malaria. Curr Opin Infect Dis 20, 598-604 (2007). (Pubitemid 350059519)
6. Ch'ng, J. H., Renia, L., Nosten, F. & Tan, K. S. Can we teach an old drug new tricks? Trends Parasitol 28, 220-224 (2012).
7. van Schalkwyk, D. A. & Egan, T. J. Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum. Drug Resist Updat 9, 211-226 (2006). (Pubitemid 44781212)
8. Dondorp, A. M. et al. Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol 8, 272-280 (2010).
9. Baird, J. K. Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother 48, 4075-4083 (2004). (Pubitemid 39434858)
10. Gross, A. S., Heuer, B. & Eichelbaum, M. Stereoselective protein binding of verapamil enantiomers. Biochem Pharmacol 37, 4623-4627 (1988). (Pubitemid 19006300)
11. Pereira, M. R. et al. In vivo and in vitro antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipine. Antimicrob Agents Chemother 55, 3115-3124 (2011).
12. Henry, M., Alibert, S., Rogier, C., Barbe, J. & Pradines, B. Inhibition of efflux of quinolinesas new therapeutic strategyinmalaria. Curr Top Med Chem8, 563-578 (2008). (Pubitemid 351982580)
13. Gbotosho, G. O. et al. Comparative study of interactions between chloroquine and chlorpheniramine or promethazine in healthy volunteers: a potential combination-therapy phenomenon for resuscitating chloroquine for malaria treatment in Africa. Ann Trop Med Parasitol 102, 3-9 (2008). (Pubitemid 351185238)
14. Fidock, D. A. et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 6, 861-871 (2000).
15. Krogstad, D. J., Schlesinger, P. H. & Herwaldt, B. L. Antimalarial agents: mechanism of chloroquine resistance. Antimicrob Agents Chemother 32, 799-801 (1988).
16. Karl, S., Wong, R. P., St Pierre, T. G. & Davis, T. M. A comparative study of a flow-cytometry-based assessment of in vitro Plasmodium falciparum drug sensitivity. Malar J 8, 294 (2009).
17. Malleret, B. et al. A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development. Sci Rep 1, 118 (2011).
18. Ch'ng, J. H., Kotturi, S. R., Chong, A. G., Lear, M. J. & Tan, K. S. A programmed cell death pathway in the malaria parasite Plasmodium falciparum has general features of mammalian apoptosis but is mediated by clan CA cysteine proteases. Cell Death Dis 1, e26 (2010).
19. Ch'ng, J. H., Liew, K., Goh, A. S., Sidhartha, E. & Tan, K. S. Drug-induced permeabilization of parasite's digestive vacuole is a key trigger of programmed cell death in Plasmodium falciparum. Cell Death Dis 2, e216 (2011).
20. Spiller, D. G., Bray, P. G., Hughes, R. H., Ward, S. A. & White, M. R. The pH of the Plasmodium falciparum digestive vacuole: holy grail or dead-end trail? Trends Parasitol 18, 441-444 (2002).
21. Ursos, L. M. & Roepe, P. D. Chloroquine resistance in the malarial parasite, Plasmodium falciparum. Med Res Rev 22, 465-491 (2002).
22. Ursos, L. M., Dzekunov, S. M. & Roepe, P. D. The effects of chloroquine and verapamil on digestive vacuolar pH of P. falciparum either sensitive or resistant to chloroquine. Mol Biochem Parasitol 110, 125-134 (2000).
23. Bhattacharjee, A. K., Kyle, D. E., Vennerstrom, J. L. & Milhous, W. K. A 3D QSAR pharmacophore model and quantum chemical structure-activity analysis of chloroquine(CQ)-resistance reversal. J Chem Inf Comp Sci 42, 1212-1220 (2002). (Pubitemid 35360307)
24. Fong, T. M., Huang, R. R. & Strader, C. D. Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor. J Biol Chem 267, 25664-25667 (1992). (Pubitemid 23013957)
25. Welker, H. A., Wiltshire, H. & Bullingham, R. Clinical pharmacokinetics of mibefradil. Clin Pharmacokinet 35, 405-423 (1998). (Pubitemid 29010173)
26. Yuan, J. et al. Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets. Science 333, 724-729 (2011).
27. Giao, P. T. & de Vries, P. J. Pharmacokinetic interactions of antimalarial agents. Clin Pharmacokinet 40, 343-373 (2001). (Pubitemid 32565596)
28. Hunt, P., Cravo, P. V., Donleavy, P., Carlton, J. M. & Walliker, D. Chloroquine resistance in Plasmodium chabaudi: are chloroquine-resistance transporter (crt) and multi-drug resistance (mdr1) orthologues involved? Mol Biochem Parasitol 133, 27-35 (2004). (Pubitemid 37510305)
29. Ecker, A., Lakshmanan, V., Sinnis, P., Coppens, I. & Fidock, D. A. Evidence that mutant PfCRT facilitates the transmission to mosquitoes of chloroquine-treated Plasmodium gametocytes. J Infect Dis 203, 228-236 (2011).
30. Kinga Modrzynska, K. et al. Quantitative genome re-sequencing defines multiple mutations conferring chloroquine resistance in rodent malaria. BMC Genomics 13, 106 (2012).
31. Miki, A., Tanabe, K., Nakayama, T., Kiryon, C. & Ohsawa, K. Plasmodium chabaudi: association of reversal of chloroquine resistance with increased accumulation of chloroquine in resistant parasites. Exp Parasitol 74, 134-142 (1992).
32. Singh, N. & Puri, S. K. Interaction between chloroquine and diverse pharmacological agents in chloroquine resistant Plasmodium yoelii nigeriensis. Acta Trop 77, 185-193 (2000).
33. Osa, Y. et al. Structural properties of dibenzosuberanylpiperazine derivatives for efficient reversal of chloroquine resistance in Plasmodium chabaudi. J Med Chem 46, 1948-1956 (2003). (Pubitemid 36532237)